Skip to search.
 TSX Down 0.42% TSX Ventures Down 1.09%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
31.44 Down 1.68(5.07%) 4:00PM EDT
|After Hours : 31.44 Down 0.00 (0.01%) 4:17PM EDT
Add to Portfolio
Prev Close:33.12
Open:33.32
Bid:30.89 x 100
Ask:33.50 x 500
1y Target Est:44.64
Beta:1.32
Next Earnings Date:30-Apr-15ACOR Earnings announcement
Day's Range:31.21 - 33.38
52wk Range:28.26 - 45.45
Volume:693,132
Avg Vol (3m):743,727
Market Cap:1.34B
P/E (ttm):74.86
EPS (ttm):0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ACORDown 5.07%1.34B
BIIBDown 3.10%91.33B
TEVADown 4.32%52.50B

Key Statistics

Forward P/E (1 yr):33.09
P/S (ttm):3.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.53
Quarterly EPS Est (Mar-15) :0.14
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback